Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T1225 vs Tobramycin in Pediatric Bacterial Conjunctivitis
NCT01155999Phase 3Completed
- Sponsor
- Laboratoires Théa
- Start
- Dec 2008
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of azithromycin in bacterial conjunctivitis (BC) (2 arms), sponsored by Laboratoires Théa. Primary endpoint: Clinical Cure in the Worse Eye at Day 3. Started Dec 2008; status: completed.
02
Drugs
azithromycin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT01155999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155999.